Pharmena S.A. (PHR) — Cash Flow-to-Debt Ratio
Pharmena S.A. (PHR) has a Cash Flow-to-Debt Ratio of -0.96x as of September 2025, meaning its operating cash flow of zł-820.00K could theoretically repay -1% of its total liabilities (zł850.00K) in one year. See Pharmena S.A. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pharmena S.A. Cash Flow-to-Debt Ratio (2008–2024)
Historical debt coverage capacity for Pharmena S.A. across 17 annual periods. Also explore PHR shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Pharmena S.A. (2008–2024)
Year-by-year debt coverage analysis for Pharmena S.A.. For market capitalisation and broader financial context, see PHR stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (PLN) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.29x | zł-2.53 Million | zł1.11 Million | ▼ -113.2% |
| 2023 | 17.33x | zł33.03 Million | zł1.91 Million | ▲ +18355.7% |
| 2022 | 0.09x | zł1.82 Million | zł19.37 Million | ▲ +147.4% |
| 2021 | -0.20x | zł-3.23 Million | zł16.27 Million | ▲ +0.2% |
| 2020 | -0.20x | zł-2.24 Million | zł11.30 Million | ▲ +89.8% |
| 2019 | -1.95x | zł-13.15 Million | zł6.74 Million | ▼ -362.6% |
| 2018 | 0.74x | zł3.61 Million | zł4.87 Million | ▲ +804.5% |
| 2017 | 0.08x | zł619.00K | zł7.54 Million | ▲ +172.1% |
| 2016 | -0.11x | zł-950.00K | zł8.34 Million | ▲ +82.3% |
| 2015 | -0.64x | zł-4.17 Million | zł6.49 Million | ▲ +57.7% |
| 2014 | -1.52x | zł-5.75 Million | zł3.78 Million | ▲ +0.6% |
| 2013 | -1.53x | zł-3.84 Million | zł2.51 Million | ▲ +1.5% |
| 2012 | -1.55x | zł-4.05 Million | zł2.61 Million | ▼ -472.2% |
| 2011 | 0.42x | zł666.91K | zł1.60 Million | ▲ +135.2% |
| 2010 | -1.18x | zł-1.08 Million | zł912.97K | ▼ -517.6% |
| 2009 | -0.19x | zł-179.22K | zł934.89K | ▼ -333.0% |
| 2008 | -0.04x | zł-32.56K | zł735.26K | — |